Pharos iBio Co., Ltd.
AI-powered drug development for rare and refractory diseases, focusing on oncology.
388870 | KO
Overview
Corporate Details
- ISIN(s):
- KR7388870008
- LEI:
- Country:
- South Korea
- Address:
- 경기도 안양시 동안구 흥안대로427번길 38, 1408호(관양동, 성지스타위드), 안양시
- Website:
- https://www.pharosibio.com/en/
- Sector:
- Mining and quarrying
- Industry:
- Mining of non-ferrous metal ores
Description
Pharos iBio Co., Ltd. is a clinical-stage biotechnology company specializing in the development of novel drugs for rare and refractory diseases, with a particular focus on oncology. The company leverages its proprietary artificial intelligence (AI) and big data platform, Chemiverse®, to accelerate the drug discovery and development process. This platform integrates multiple modules, including protein structure analysis, to identify and optimize new drug candidates from target identification through to the preclinical stage. The company has successfully advanced its AI-developed therapies into clinical trials, notably for conditions like acute myeloid leukemia (AML), aiming to provide innovative treatments for patients with high unmet medical needs.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-08-13 00:00 |
Interim Report
반기보고서 (2025.06)
|
Korean | 1.2 MB | ||
| 2025-07-21 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.3 KB | ||
| 2025-07-16 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.3 KB | ||
| 2025-06-30 00:00 |
Legal Proceedings Report
투자판단관련주요경영사항(임상시험결과) (경구용 항암제 PHI101의 임상 1상 임상시험결과보고서(CSR) 수령)
|
Korean | 14.4 KB | ||
| 2025-06-26 00:00 |
Legal Proceedings Report
[기재정정]투자판단관련주요경영사항(임상시험계획승인신청등결정) (BRAF, KRAS 또는 NRAS 돌연변이를 가진 진행성…
|
Korean | 15.8 KB | ||
| 2025-06-25 00:00 |
Legal Proceedings Report
투자판단관련주요경영사항(임상시험계획승인신청등결정) (BRAF, KRAS 또는 NRAS 돌연변이를 가진 진행성 고형암 환…
|
Korean | 12.3 KB | ||
| 2025-05-15 00:00 |
Quarterly Report
분기보고서 (2025.03)
|
Korean | 956.3 KB | ||
| 2025-03-25 00:00 |
Post-Annual General Meeting Information
정기주주총회결과
|
Korean | 25.3 KB | ||
| 2025-03-25 00:00 |
Share Issue/Capital Change
주식매수선택권부여에관한신고
|
Korean | 18.2 KB | ||
| 2025-03-18 00:00 |
Audit Report / Information
사업보고서 (2024.12)
|
Korean | 364.5 KB | ||
| 2025-03-17 00:00 |
Audit Report / Information
감사보고서제출
|
Korean | 26.0 KB | ||
| 2025-03-07 00:00 |
Pre-Annual General Meeting Information
주주총회소집공고
|
Korean | 173.4 KB | ||
| 2025-03-05 00:00 |
Regulatory News Service
투자판단관련주요경영사항(임상시험계획승인신청) (BRAF, KRAS 또는 NRAS 돌연변이를 가진 진행성 고형암 환자를 …
|
Korean | 9.3 KB | ||
| 2025-02-10 00:00 |
Pre-Annual General Meeting Information
주주총회소집결의
|
Korean | 12.2 KB | ||
| 2024-12-20 00:00 |
Share Issue/Capital Change
[기재정정]주식매수선택권부여에관한신고
|
Korean | 18.2 KB |
Automate Your Workflow. Get a real-time feed of all Pharos iBio Co., Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Pharos iBio Co., Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Pharos iBio Co., Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
